Stock Analysts’ Updated EPS Estimates for December 18th (AAOI, AGIO, ALXO, ANGI, BBY, BCDA, BLDR, CADL, CASY, COTY)

Stock Analysts’ updated eps estimates for Wednesday, December 18th:

Applied Optoelectronics (NASDAQ:AAOI) had its outperform rating reissued by analysts at Northland Securities. Northland Securities currently has a $40.00 target price on the stock, up from their previous target price of $25.00.

Agios Pharmaceuticals (NASDAQ:AGIO) had its overweight rating reiterated by analysts at Cantor Fitzgerald.

ALX Oncology (NASDAQ:ALXO) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $25.00 price target on the stock.

ALX Oncology (NASDAQ:ALXO) had its overweight rating reiterated by analysts at Cantor Fitzgerald.

Angi (NASDAQ:ANGI) had its neutral rating reiterated by analysts at JPMorgan Chase & Co..

Best Buy (NYSE:BBY) had its buy rating reiterated by analysts at Loop Capital. Loop Capital currently has a $100.00 price target on the stock.

BioCardia (NASDAQ:BCDA) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $25.00 target price on the stock.

Builders FirstSource (NYSE:BLDR) had its outperform rating reiterated by analysts at Wedbush. They currently have a $230.00 price target on the stock.

Candel Therapeutics (NASDAQ:CADL) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $19.00 target price on the stock, up from their previous target price of $11.00.

Casey’s General Stores (NASDAQ:CASY) had its market perform rating reiterated by analysts at BMO Capital Markets. BMO Capital Markets currently has a $450.00 target price on the stock, up from their previous target price of $400.00.

Coty (NYSE:COTY) had its buy rating reaffirmed by analysts at DA Davidson. DA Davidson currently has a $12.50 price target on the stock.

Coya Therapeutics (NASDAQ:COYA) had its buy rating reiterated by analysts at D. Boral Capital. D. Boral Capital currently has a $15.00 target price on the stock.

Cardiol Therapeutics (NASDAQ:CRDL) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $9.00 target price on the stock.

Salesforce (NYSE:CRM) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $375.00 target price on the stock.

Salesforce (NYSE:CRM) had its market outperform rating reiterated by analysts at JMP Securities. The firm currently has a $450.00 target price on the stock.

Salesforce (NYSE:CRM) had its overweight rating reiterated by analysts at Piper Sandler. Piper Sandler currently has a $405.00 target price on the stock.

Salesforce (NYSE:CRM) had its outperform rating reaffirmed by analysts at Wedbush. The firm currently has a $425.00 price target on the stock.

Electronic Arts (NASDAQ:EA) had its hold rating reissued by analysts at Stifel Nicolaus. They currently have a $167.00 target price on the stock.

EVERTEC (NYSE:EVTC) had its outperform rating reiterated by analysts at William Blair.

Endeavour Silver (NYSE:EXK) (TSE:EDR) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $7.25 price target on the stock.

Foot Locker (NYSE:FL) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $25.00 target price on the stock.

Fluence Energy (NASDAQ:FLNC) had its neutral rating reissued by analysts at Robert W. Baird. They currently have a $20.00 price target on the stock, down from their previous price target of $24.00.

Fluor (NYSE:FLR) had its neutral rating reiterated by analysts at Robert W. Baird. Robert W. Baird currently has a $58.00 price target on the stock, up from their previous price target of $54.00.

Getty Images (NYSE:GETY) had its underweight rating reiterated by analysts at JPMorgan Chase & Co..

G-III Apparel Group (NASDAQ:GIII) had its market perform rating reaffirmed by analysts at Telsey Advisory Group. The firm currently has a $38.00 target price on the stock.

Gaming and Leisure Properties (NASDAQ:GLPI) had its market outperform rating reissued by analysts at JMP Securities. The firm currently has a $55.00 target price on the stock.

GeoVax Labs (NASDAQ:GOVX) had its buy rating reissued by analysts at D. Boral Capital. The firm currently has a $18.00 price target on the stock.

Structure Therapeutics (NASDAQ:GPCR) had its market outperform rating reissued by analysts at JMP Securities. The firm currently has a $91.00 price target on the stock.

Halliburton (NYSE:HAL) had its equal weight rating reaffirmed by analysts at Barclays PLC. Barclays PLC currently has a $33.00 target price on the stock, down from their previous target price of $43.00.

Halozyme Therapeutics (NASDAQ:HALO) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $68.00 target price on the stock.

Heart Test Laboratories (NASDAQ:HSCS) had its buy rating reaffirmed by analysts at Maxim Group. The firm currently has a $12.00 price target on the stock.

ICON Public (NASDAQ:ICLR) had its buy rating reiterated by analysts at Truist Financial Co.. The firm currently has a $284.00 target price on the stock, down from their previous target price of $295.00.

Immersion (NASDAQ:IMMR) had its buy rating reaffirmed by analysts at BWS Financial. The firm currently has a $13.50 price target on the stock.

Inter Parfums (NASDAQ:IPAR) had its buy rating reissued by analysts at DA Davidson. They currently have a $163.00 target price on the stock.

Joby Aviation (NYSE:JOBY) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $9.00 price target on the stock.

Kosmos Energy (NYSE:KOS) had its buy rating reiterated by analysts at Jefferies Financial Group Inc.. They currently have a $5.60 target price on the stock.

Krystal Biotech (NASDAQ:KRYS) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $221.00 target price on the stock.

Krystal Biotech (NASDAQ:KRYS) had its buy rating reissued by analysts at Chardan Capital. Chardan Capital currently has a $212.00 price target on the stock.

Lifezone Metals (NYSE:LZM) had its buy rating reaffirmed by analysts at Roth Mkm. They currently have a $14.00 target price on the stock.

monday.com (NASDAQ:MNDY) had its outperform rating reiterated by analysts at William Blair.

monday.com (NASDAQ:MNDY) had its overweight rating reissued by analysts at Piper Sandler. Piper Sandler currently has a $350.00 price target on the stock.

Match Group (NASDAQ:MTCH) had its neutral rating reissued by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $33.00 price target on the stock, down from their previous price target of $40.00.

Micron Technology (NASDAQ:MU) had its buy rating reissued by analysts at Rosenblatt Securities. The firm currently has a $250.00 price target on the stock.

PLAYSTUDIOS (NASDAQ:MYPS) had its underweight rating reiterated by analysts at JPMorgan Chase & Co..

PDS Biotechnology (NASDAQ:PDSB) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $21.00 target price on the stock.

Palantir Technologies (NYSE:PLTR) had its underperform rating reaffirmed by analysts at William Blair.

Pactiv Evergreen (NASDAQ:PTVE) had its hold rating reiterated by analysts at Jefferies Financial Group Inc.. They currently have a $18.00 target price on the stock, up from their previous target price of $15.00.

RCI Hospitality (NASDAQ:RICK) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $98.00 price target on the stock.

Rivian Automotive (NASDAQ:RIVN) had its neutral rating reaffirmed by analysts at Robert W. Baird. Robert W. Baird currently has a $16.00 price target on the stock, down from their previous price target of $18.00.

RenaissanceRe (NYSE:RNR) had its hold rating reissued by analysts at Jefferies Financial Group Inc.. They currently have a $282.00 target price on the stock, down from their previous target price of $304.00.

SBA Communications (NASDAQ:SBAC) had its market perform rating reissued by analysts at BMO Capital Markets. The firm currently has a $230.00 price target on the stock, down from their previous price target of $260.00.

Stardust Power (NASDAQ:SDST) had its buy rating reaffirmed by analysts at Roth Mkm. The firm currently has a $13.00 price target on the stock.

Taboola.com (NASDAQ:TBLA) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $5.00 price target on the stock.

Tenaya Therapeutics (NASDAQ:TNYA) had its buy rating reiterated by analysts at Chardan Capital. Chardan Capital currently has a $18.00 target price on the stock.

Tenaya Therapeutics (NASDAQ:TNYA) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $18.00 price target on the stock.

Uber Technologies (NYSE:UBER) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. The firm currently has a $90.00 price target on the stock.

Valaris (NYSE:VAL) had its equal weight rating reaffirmed by analysts at Barclays PLC. The firm currently has a $49.00 price target on the stock, down from their previous price target of $59.00.

Viking Therapeutics (NASDAQ:VKTX) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $102.00 price target on the stock.

Western Copper & Gold (NYSE:WRN) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $4.25 price target on the stock.